Clinical Review

Hepatitis C Virus Infections Underreported

National data not representative of complete picture


 

References

Formal surveillance reporting of acute hepatitis C virus (HCV) infection clinical diagnoses were grossly underascertained, according to a review of cases reported to the Massachusetts Department of Public Health (MDPH) and Centers for Disease Control and Prevention.

Investigators assessed rates of electronic case reporting of acute HCV infection to MDPH and rate of subsequent confirmation according to the national case definition and found:

• Of 183 clinical cases, 149 were reported to MDPH.

• Of 149 reports, MDPH investigated 43 reports based on surveillance requirements.

• Only 1 case met the national criteria and was reported to the CDC.

The authors noted hurdles to accurate case ascertainment included incomplete clinician reporting, problematic case definitions, limitations of diagnostic testing, and imperfect data captures.

Citation: Onofrey S, Aneja J, Haney GA, et al. Underascertainment of acute hepatitis C virus infections in the U.S. Surveillance System: a case series and chart review. Ann Intern Med. 2015. doi:10.7326/M14-2939. [Epub ahead of print]

Commentary: Hepatitis C, for which there is now effective and well-tolerated treatment, is an important public health problem affecting over 180 million people worldwide. The USPSTF now recommends screening for Hep C in persons at high risk for infection and also a 1-time screening for HCV infection to adults born between 1945 and 1965.1 Unlike Hep A and Hep B, where the definition of an acute infection is clear with detection of IgM antibody, the definition of acute Hep C is based on a combination of symptoms, laboratory assessments including antibodies to HCV and nucleic acid testing, as well as elevated aminotransferase levels. This study shows that the current estimates of the incidence of new Hepatitis C infections are very inexact. —Neil Skolnik, MD

Citation: Hepatitis C: Screening. US Preventive Services Task Force website.www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening. Updated June 2013. Accessed July 13, 2015.

Recommended Reading

HCV Treatment Delays Dented Efficacy in Era Before All-oral Therapy
Clinician Reviews
Significant Worker Productivity Gains With Newer Hepatitis C Drugs
Clinician Reviews
FDA Report Provides Overview of HCV Drug Approvals
Clinician Reviews
SVR Rates Slump With Real-world Use of Sofosbuvir-based HCV Regimens
Clinician Reviews
Europe Issues Hepatitis C Treatment Priority List
Clinician Reviews
Avoiding Diabetes in Patients With Hepatitis C
Clinician Reviews
VIDEO: New and Emerging Options for Management of NAFLD
Clinician Reviews
ILC: Direct Antivirals Safely Clear HCV Despite ESRD
Clinician Reviews
Online Recommendations Provide Constantly Updated HCV Management Guidelines
Clinician Reviews
DDW: Single Daily Pill Knocks out HCV in Prior Nonresponders
Clinician Reviews